These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 2480396

  • 1. [Serodiagnostic tests by factor analysis and stepwise discriminating analysis with tumor markers for the detection of ovarian cancer].
    Kobayashi H, Sumimoto K, Terao T, Kawashima Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):1903-10. PubMed ID: 2480396
    [Abstract] [Full Text] [Related]

  • 2. [Field trial of the early detection in patients with ovarian cancer].
    Kobayashi H, Sumimoto K, Terao T, Kawashima Y, Kouda M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1743-9. PubMed ID: 2480393
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Accuracy of tissue polypeptide specific antigen (TPS) in the diagnosis of ovarian malignancy.
    Padungsutt P, Thirapagawong C, Senapad S, Suphanit I.
    Anticancer Res; 2000 Nov; 20(2B):1291-5. PubMed ID: 10810437
    [Abstract] [Full Text] [Related]

  • 9. [Tumor markers of ovarian cancer].
    Nozawa S.
    Rinsho Byori; 1992 Apr; 40(4):349-53. PubMed ID: 1593759
    [Abstract] [Full Text] [Related]

  • 10. [Primary research on saliva and serum CA125 assays for detecting malignant ovarian tumors].
    Chen DX, Li FQ.
    Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):84-5, 123-4. PubMed ID: 2364796
    [Abstract] [Full Text] [Related]

  • 11. [Predictive value of a tumor marker combination for the monitoring of ovarian cancer].
    Lahousen M.
    Wien Klin Wochenschr; 1986 May 16; 98(10):319-25. PubMed ID: 3460273
    [Abstract] [Full Text] [Related]

  • 12. Circulating mucins as tumor markers in ovarian cancer (review).
    Devine PL, McGuckin MA, Ward BG.
    Anticancer Res; 1992 May 16; 12(3):709-17. PubMed ID: 1622128
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
    Sedlaczek P, Frydecka I, Gabryś M, Van Dalen A, Einarsson R, Harłozińska A.
    Cancer; 2002 Nov 01; 95(9):1886-93. PubMed ID: 12404282
    [Abstract] [Full Text] [Related]

  • 16. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
    Kataoka A, Yakushiji M.
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan 20; 25(1):47-54. PubMed ID: 2157782
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Tumor marker--screening for gynecological cancer; personal experience. Utility of tumor markers in screening of ovarian cancer].
    Kimura E, Kobayashi S, Terashima Y.
    Gan To Kagaku Ryoho; 1990 Dec 20; 17(12):2443-50. PubMed ID: 2260879
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT, Boardman CH, Lafky JM, Rademaker A, Liu D, Fishman DA, Podratz KC, Maihle NJ.
    Cancer Epidemiol Biomarkers Prev; 2005 Feb 20; 14(2):306-18. PubMed ID: 15734951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.